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Scientists Pinpoint aProtein Critical to the Function ofthe Ebola Virus 

By Steven Bradt 
Scientists at the University of Pennsylva­nia's School ofVeterinary Medicine have identified a sequence of just four amino 
acids in a key viral protein that may be critical 
to the spread of the Ebola virus. Their findings, 
reported in the Dec. 5 issue of the Proceedings 
ofthe National Academy ofSciences, offer the 
promise of future treatments for Ebola out­
breaks that prove fatal for up to 90 percent of 
victims. 
Ebola hemorrhagic fever is one of the most 
dangerous and ghastly viral diseases known to 
humans, but much about the underlying virus 
continues to elude researchers, said lead author 
Ronald N. Harty, Ph.D, assistant professor of 
microbiology. Like all viruses, Ebola requires a 
host in order to replicate, invading host cells 
and using them as factories to crank out 
countless copies of its own genetic material. 
Harty's work indicates that after this newly 
created RNA is packaged into viral protein 
coats, the newborn viruses rely on the little­
known VP40 protein to traverse the cell's 
membrane, exiting the cell by simply budding 
off from it. These viruses proceed to infect 
other host cells until the cumulative effect of 
this explosive viral proliferation overwhelms 
the body. 
On the cover 
Linda, a 13 year old African elephant, 
was seen at New Bolton Center for diag­
nostic radiographs of her leg. To keep 
her content, her two constant compan­
ions, Shanna, a 17 year old African ele­
phant, and Cora, a 44 year old Asian ele­
phant, accompanied her. All three went 
to radiology, and the two older ones 
watched while technicians took the radi­
ographs of the younger elephant's leg. 
Once the procedure was complete the 
"family group" walked back to the trailer 
in a line, trunks holding tails. 
The function ofVP40, found directly under 
the virus's external coat, had previously been 
unknown. Harty worked with the isolated pro­
I tein and single mammalian cells to discover 
I that a short segment ofVP40 appears to be 
what enables Ebola to slip out of host cells. 
"This new understanding of the role VP40 
I plays in Ebola's replication cycle could be a 
critical first step in the development of new 
antiviral drugs to combat Ebola;' said Harty. 
"Now that we've identified this vital region of I 
this key protein, we may have a target for new 
Ebola-fighting medications:' 
Because Ebola hemorrhagic fever occurs 
only in relatively small, sporadic outbreaks, 
Harty said antiviral drugs represent a logical 
approach to controlling the disease. There is 
currently no specific treatment other than the 
administration of intravenous fluids to combat 
severe dehydration. 
Harty's findings implicate a proline-rich 
sequence of amino acids within VP40 as the 
key to its ability to bud efficiently from cell 
membranes. This segment of the protein ­
dubbed a PPxY motif because of its signature 
sequence of two prolines (P) and a tyrosine 
I (Y) separated by any single amino acid - inter­
acts physically and functionally with cell 
enzymes known as ubiquitin ligases. Such a 
virus-host interaction is thought to be crucial 
for the virus to escape from the cell. 
One of just seven proteins produced by 
Ebola, VP40 was significantly impaired in its 
ability to exit mammalian cells by even the 
slightest mutations affecting the PPxY motif, 
Harty found. 
"Motifs similar or identical to PPxY are also 
common in other viruses, including HN and 
the virus responsible for rabies;' Harty said. "In 
each case, they function in virus release from 
infected cells, and they may carry out this func­
tion by mediating interactions with host cell 
proteins." 
Harty was joined in the research by Melissa 
E. Brown and Felicia P. Hayes at Penn and by 
Guangli Wang and Jon Huibregtse at the 
University of Texas at Austin. The work was 
funded by the University of Pennsylvania 
Research Foundation. 
About Eboia hemorrhagicfever 
World Health Organization statistics 
indicate that Ebola hemorrhagic fever has 
killed 793 of 1,100 known victims since it 
was first identified in Sudan and Zaire in 
1976. Ebola is believed to originate in the 
jungles ofAfrica and Asia, although it's not 
known where, how or in what carrier 
species the virus lies dormant between 
outbreaks. 
Ebola is transmitted through close 
contact with bodily fluids, such as mucus, 
saliva and blood. Ebola hemorrhagic fever 
can take days or weeks to incubate, mani­
festing itself only with the sudden onset of 
fever, weakness, muscle pain, headache 
and sore throat, followed by vomiting, 
diarrhea, rashes and reduced kidney and 
liver functions. Later, victims start to hem­
orrhage and bleed through the nose, 
mouth, eyes and other orifices. Blood and 
other bodily fluids also begin seeping 
through the skin, producing painful 
blisters. 
The last major Ebola outbreak was in 
1995 in Zaire, with as many as 300 lives 
lost; the most recent outbreak, in Uganda, 
killed more than 100 people several 
months ago. Because the virus typically 
kills its victims faster than it can spread, 
outbreaks have usually been extinguished 
before spreading very far. 
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